June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Electronretinogram and aqueous vascular endotheril growth factor in the eyes with hemi-central retinal vein occlusion or branch retinal vein occlusion
Shu Kachi; Shunsuke Yasuda; Hiroaki Ushida; Mineo Kondo; Shinji Ueno; Changhua Piao; Hiroko Terasaki
Author Affiliations & Notes
  • Shu Kachi
    Ophthalmology, Nagoya University, Nagoya, Japan
  • Shunsuke Yasuda
    Ophthalmology, Nagoya University, Nagoya, Japan
  • Hiroaki Ushida
    Ophthalmology, Nagoya University, Nagoya, Japan
  • Mineo Kondo
    Ophthalmology, Nagoya University, Nagoya, Japan
  • Shinji Ueno
    Ophthalmology, Nagoya University, Nagoya, Japan
  • Changhua Piao
    Ophthalmology, Nagoya University, Nagoya, Japan
  • Hiroko Terasaki
    Ophthalmology, Nagoya University, Nagoya, Japan
  • Footnotes
    Commercial Relationships Shu Kachi, None; Shunsuke Yasuda, None; Hiroaki Ushida, None; Mineo Kondo, None; Shinji Ueno, None; Changhua Piao, None; Hiroko Terasaki, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5124. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Electronretinogram and aqueous vascular endotheril growth factor in the eyes with hemi-central retinal vein occlusion or branch retinal vein occlusion
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      Shu Kachi, Shunsuke Yasuda, Hiroaki Ushida, Mineo Kondo, Shinji Ueno, Changhua Piao, Hiroko Terasaki; Electronretinogram and aqueous vascular endotheril growth factor in the eyes with hemi-central retinal vein occlusion or branch retinal vein occlusion. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5124.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Purpose: A hemi-central retinal vein occlusion (hCRVO) is a disease related to a CRVO but not to a branch retinal vein occlusion (BRVO). A CRVO leads to retinal ischemia which induces an up-regulation of vascular endothelial growth factor (VEGF). The up-regulation of VEGF can lead to iris neovascularization. Similar changes occur in eyes with hCRVO but not in eyes with BRVO. We have reported that there is correlation between aqueous VEGF level and the implicit time of 30 Hz flicker ERG in eyes with a CRVO. The purpose of this study was to determine whether there are differences in the level of VEGF in the aqueous and in the amplitudes and implicit times of different components of the electroretinograms (ERGs) in eyes with a hCRVO or with a BRVO.

Methods: The medical records of patients who had macular edema secondary to a hCRVO (7 eyes) or a BRVO (13 eyes) and had received an intravitreal injection of bevacizumab (IVB) at the Nagoya University Hospital from July 2009 to August 2012 were reviewed. ERGs were recorded according to the protocol of the ISCEV, and they were recorded before the IVB. Aqueous humor was collected before the IVB and the VEGF concentration was measured by ELISA.

Results: The mean VEGF concentration in the aqueous humor in the hCRVO eyes was significantly higher than that in the BRVO eyes (622 vs 149 pg/mL, P<0.05). The implicit time of the 30 Hz flicker ERGs was significantly longer in eyes with a hCRVO than eyes with a BRVO (34 vs. 30 msec, P<0.05), and the amplitude of cone b-wave were significantly smaller in the hCRVO than the BRVO eyes (47 vs. 68 uV, P<0.05). There was no significant differences in the other ERG components.

Conclusions: The significant differences in the aqueous VEGF level and in the implicit time of the 30 Hz flicker ERG between eyes with a hCRVO and BRVO suggest that the ERG findings can be used to estimate the aqueous level of VEGF and determine whether there is a risk of developing iris neovascularization in eyes with hCRVO and BRVO.

Keywords: 509 electroretinography: clinical • 748 vascular endothelial growth factor • 749 vascular occlusion/vascular occlusive disease  
© 2013, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept